SCHEMBL6583773

SCHEMBL6583773

O=C(O)C=C(Nc1ccccc1[N+](=O)[O-])C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
RAB9A P51151 3/20 0.52
GAA P10253 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP3A4 P08684 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
KCNMA1 Q12791 1/20 0.51
NPC1 O15118 3/20 0.51
MAPT P10636 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
ALDH1A1 P00352 4/20 0.50
POLB P06746 2/20 0.50
PHGDH O43175 1/20 0.50
MAPK1 P28482 3/20 0.49
CASP7 P55210 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
PDK1 Q15118 1/20 0.48
PDK2 Q15119 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6583777 1.00 MEN1 (0.62) MEN1KMT2ARAB9AGAACYP2C9
SCHEMBL6583771 1.00 MEN1 (0.62) MEN1KMT2ARAB9AGAACYP2C9
SCHEMBL6080754 0.86 KMT2A (0.56) MEN1KMT2ARAB9AGAACYP2C9
SCHEMBL10874799 0.86 ALDH1A1 (0.66) MEN1KMT2ARAB9AGAACYP2C9
SCHEMBL10874791 0.86 ALDH1A1 (0.66) MEN1KMT2ARAB9AGAACYP2C9
SCHEMBL6587509 0.84 ABCC1 (0.59) MEN1KMT2ARAB9ACYP2C9CYP2C19
SCHEMBL6587318 0.80 ALDH1A1 (0.66) KMT2ARAB9AGAACYP2C9KCNMA1
SCHEMBL6589695 0.80 ALDH1A1 (0.52) KMT2ARAB9ACYP3A4NPSR1KCNMA1
SCHEMBL6584488 0.80 MAPK1 (0.50) MEN1KMT2ARAB9AGAANPSR1
SCHEMBL6589705 0.80 ALDH1A1 (0.52) KMT2ARAB9ACYP3A4NPSR1KCNMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451159-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2004-09-01 EP disclosed
WO-2003010146-A1 COMPOSITIONS DERIVED FROM QUINOLINE AND QUINOXALINE, PREPARATION AND USE THEREOF NEURO3D (FR) 2003-02-06 WO disclosed